Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis.
- DOI
- 10.1093/ibd/izaf319
- Published
- 2026-05-01
- Container
- Inflamm Bowel Dis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ibd/izaf319,
title = {Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis.},
author = {Rubin DT and Danese S and Nakase H and Ungaro RC and Wolf DC and Alekseeva O and Petersen A and Liu Z and Mehra D and Jain A and Osterman MT and Krakovich A and Riolo JV and DeBoer E and Appio J and Sinh P and Cree BAC and Cohen JA and Irving P.},
year = {2026},
journal = {Inflamm Bowel Dis},
doi = {10.1093/ibd/izaf319},
url = {https://doi.org/10.1093/ibd/izaf319}
}RIS
TY - JOUR TI - Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis. AU - Rubin DT AU - Danese S AU - Nakase H AU - Ungaro RC AU - Wolf DC AU - Alekseeva O AU - Petersen A AU - Liu Z AU - Mehra D AU - Jain A AU - Osterman MT AU - Krakovich A AU - Riolo JV AU - DeBoer E AU - Appio J AU - Sinh P AU - Cree BAC AU - Cohen JA AU - Irving P. PY - 2026 JO - Inflamm Bowel Dis DO - 10.1093/ibd/izaf319 UR - https://doi.org/10.1093/ibd/izaf319 ER -
APA
DT, R., S, D., H, N., RC, U., DC, W., O, A., A, P., Z, L., D, M., A, J., MT, O., A, K., JV, R., E, D., J, A., P, S., BAC, C., JA, C., & P., I. (2026). Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis.. Inflamm Bowel Dis. https://doi.org/10.1093/ibd/izaf319
Source records
- europe-pmc · retrieved 2026-09-26T17:52:02.940Z